None listed
Conditions
Interventions
None listed
Sponsors
Gachon University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Male and female children aged 12 to 30 months 2) Those who meet the criteria for autism spectrum disorder in the DSM-5 3) A child who has been diagnosed with autism spectrum disorder mild concern or higher on the toddler module, or autism spectrum disorder or autism on the module 2 by ADOS 2 test by a qualified clinical psychologist 4) A person whose legal representative voluntarily signed an IRB-approved research consent form
Exclusion criteria
Exclusion criteria: 1) In case of accompanying neurological abnormalities (epilepsy, cerebral palsy, Down syndrome, etc.) 2) Those diagnosed with attention deficit hyperactivity disorder, schizophrenia, etc. 3) A person diagnosed with a serious chronic or terminal disease (malignant tumor, tuberculosis, etc.) 4) If you are taking risperidone or aripiprazole, it has been less than 3 months since you stopped taking it 5) If you are taking health functional food to improve autism spectrum disorder, a person who has been taking it for less than 2 weeks after stopping taking it 6) Those who are judged unsuitable for participation in research by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Childhood Autism Rating Scale, Second Edition | — |
Secondary
| Measure | Time frame |
|---|---|
| Autism Diagnostic Observation Schedule™, Second Edition;Autism Behavior Checklist;Social Maturity Scale;Clinical Global Impression-Severity;Clinical Global Impression of Change;Patient Global Impression of Change;blood test;Adverse events investigation | — |
Countries
Korea, Republic of
Contacts
Public ContactBoram Lee
Korea Institute of Oriental Medicine
Outcome results
None listed